Saltar al contenido principal

Advances in Cancer Research

Genomics in Cancer Drug Discovery and Development

  • 1 Edición, Volumen 96 - 15 de diciembre de 2006
  • Última edición
  • Editores: George F. Vande Woude, Garret Hampton, Karol Sikora, George Klein
  • Idioma: Inglés

The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever themat… Leer más

Descripción

The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States, Europe and Japan.

De interès para

Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.

Índice

Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug Approval in the United States, Europe and Japan.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 96
  • Publicado: 15 de diciembre de 2006
  • Idioma: Inglés

Sobre los editores

GV

George F. Vande Woude

Afiliaciones y experiencia
Director, Van Andel Research Institute, Grand Rapids, MI, USA NCI-Frederick Cancer Research Facility Frederick, Maryland ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland

GH

Garret Hampton

Afiliaciones y experiencia
Celgene Signal Research, San Diego, CA, U.S.A.

KS

Karol Sikora

Afiliaciones y experiencia
Professor, Hammersmith Hospital, Hammersmith, U.K.

GK

George Klein

Afiliaciones y experiencia
Karolinska Insitutet, Stockholm, Sweden

Ver libro en ScienceDirect

Lee Advances in Cancer Research en ScienceDirect